NEW YORK May 26 2017 PRNewswire Immune Pharmaceuticals Inc. NASDAQ IMNP the "Company" announced today that on May 24 2017 the Company received written notice from Nasdaq that the Company has regained compliance with the minimum bid price rule as...
↧